INS and End Stage Liver Disease: The best treatment strategy is represented by insulin and phlebotomies which can delay the need for insulin therapy, required when ß-cells are no longer able to maintain glucose homeostasis, while liver transplantation is indicated only in cases of end-stage liver disease due to iron overload and cirrhosis (5, 8, 101).